| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99308 |
Subsequent nursing facility care, per day, straightforward |
9,538 |
3,218 |
$337K |
| 99305 |
|
1,587 |
1,313 |
$91K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,872 |
1,550 |
$88K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
620 |
551 |
$46K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
642 |
369 |
$37K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
560 |
560 |
$29K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
455 |
453 |
$21K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
620 |
551 |
$15K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
97 |
96 |
$8K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
94 |
86 |
$7K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
212 |
212 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
385 |
363 |
$5K |
| 51798 |
|
725 |
704 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
822 |
749 |
$5K |
| 99307 |
|
214 |
112 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
650 |
593 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
217 |
119 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
288 |
283 |
$2K |
| 99442 |
|
62 |
40 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
43 |
43 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
44 |
44 |
$2K |
| 87070 |
|
192 |
161 |
$1K |
| 99304 |
|
34 |
32 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
223 |
202 |
$1K |
| 87184 |
|
192 |
161 |
$1K |
| 99306 |
Prolong nursin fac eval 15m |
12 |
12 |
$396.00 |
| 94760 |
|
2,643 |
2,256 |
$163.57 |
| 99201 |
|
49 |
49 |
$158.30 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
39 |
37 |
$79.23 |
| 81000 |
|
18 |
17 |
$66.58 |
| 90686 |
|
93 |
93 |
$62.03 |
| 99050 |
|
20 |
19 |
$57.60 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
51 |
47 |
$56.59 |
| 36415 |
Collection of venous blood by venipuncture |
42 |
42 |
$3.00 |
| 90461 |
|
105 |
104 |
$0.00 |
| 99080 |
|
46 |
22 |
$0.00 |
| 36416 |
|
12 |
12 |
$0.00 |